Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
Abstract Background COVID-19 pandemic has claimed millions of lives and devastated the health service system, livelihood, and economy in many countries worldwide. Despite the vaccination programs in many countries, the spread of the pandemic continues, and effective treatment is still urgently neede...
Saved in:
Main Authors: | Kunlakanya Jitobaom (Author), Chompunuch Boonarkart (Author), Suwimon Manopwisedjaroen (Author), Nuntaya Punyadee (Author), Suparerk Borwornpinyo (Author), Arunee Thitithanyanont (Author), Panisadee Avirutnan (Author), Prasert Auewarakul (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)
by: Taweegrit Siripongboonsitti, et al.
Published: (2024) -
Immortalized stem cell-derived hepatocyte-like cells: An alternative model for studying dengue pathogenesis and therapy.
by: Kessiri Kongmanas, et al.
Published: (2020) -
Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters
by: Allegra Peletta, et al.
Published: (2022) -
Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
by: Nuttapat Pisuttinusart, et al.
Published: (2024) -
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020)